GENEFRONTIER CORP has a total of 46 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SYNIMMUNE GMBH, XENCOR INC and F STAR BIOTECH FORSCH & ENTW.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | China | 4 | |
#7 | Japan | 4 | |
#8 | South Africa | 3 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Chemical engineering | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Combinatorial chemistry | |
#6 | Chemical or physical processes | |
#7 | Fermentation | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Miyakoshi Akira | 32 |
#2 | Kojoh Kanehisa | 30 |
#3 | Katoh Shizue | 24 |
#4 | Nakamura Mikiko | 22 |
#5 | Mochizuki Satsuki | 21 |
#6 | Hayami Yuki | 21 |
#7 | Okada Yasunori | 20 |
#8 | Shimoda Masayuki | 15 |
#9 | Tsuihiji Kumiko | 15 |
#10 | Matsumoto Rena | 10 |
Publication | Filing date | Title |
---|---|---|
WO2021070696A1 | Cyclic peptide having ctla-4 inhibitory activity and use thereof | |
WO2018131718A1 | Method for producing polypeptide having dna-specific adp-ribosylation activity | |
EP3266799A1 | Anti-human membrane-type adam28 antibody | |
CN105849128A | Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases | |
EP3473718A1 | Anti-adam28 antibody for treating cancer | |
EP2657334A1 | Efficient method for displaying protein multimer | |
EP2843051A1 | Anti-human cd69 antibody, and use thereof for medical purposes | |
SG187046A1 | Rnf8-fha domain-modified protein and method of producing the same | |
JP2012187049A | Composition for synthesizing protein with reduced lipopolysaccharide contamination and method for producing protein by using the composition | |
JP2008000131A | Method for evaluating physiological state of test aquatic organism |